Stay updated on Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s displayed site/browser revision has been updated from version v3.5.2 to v3.5.3, indicating a platform/UI maintenance update rather than a change to the trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T22:27:21.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:12:22.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    New revision v3.5.0 has been added to the Record History. The revision v3.4.3 entry has been removed.
    Difference
    0.1%
    Check dated 2026-03-20T00:22:03.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Added a new revision entry v3.4.3 and deleted revision v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-05T18:29:46.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    A new revision tag (v3.4.2) was added to the record history, replacing the previous v3.4.1, indicating a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T03:59:11.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision history shows a new Revision: v3.4.1 and removal of Revision: v3.4.0, a minor update to the page's revision log. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T01:52:07.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.